Adjuvance Technologies Announces NIH Funding for COVID-19 Vaccine Research
Adjuvance Technologies Inc., a member of Bio Nebraska, announced that they have been awarded supplemental contract funding from the National Institute of Allergy and Infectious Diseases (NIAID). Read more